Illumina Strengthens Proteomics Capabilities with SomaLogic Acquisition

Illumina finalizes the acquisition of SomaLogic, expanding its multiomics portfolio and enhancing access to proteomic insights at scale. The $350 million cash acquisition strategically positions Illumina for growth in the proteomics market.